Your Best Stock
Stocks Biotechnology VRTX

Vertex Pharmaceuticals VRTX

US equityMarket cap rank #116BiotechnologyGene Editing
$520.94
+$4.60 (+0.89%)
Market open · Sep 24, 1:10 pm ET
After hours $517.00 +0.13%
Open$515.56
Prev close$516.34
Day range$515.30 – $528.89
Volume332.9K
Market cap$132.04B
P/E (TTM)30.3
Dividend yield

Valuation

Multiples measured against the stock's own five-year history

Price / earnings29.9x
CheapRich

Above its usual level · 79th percentile, 5-year average -19.3x

#2069 of 2975 stocks by PE (1 = cheapest)

Price / book6.4x
CheapRich

Above its usual level · 61st percentile, 5-year average 6.4x

#4541 of 5302 stocks by PB (1 = cheapest)

Price / sales10.3x
CheapRich

Above its usual level · 68th percentile, 5-year average 9.8x

#4414 of 5141 stocks by PS (1 = cheapest)

P/E over five years

-290x-159x-27x105xSep '21Mar '24Sep '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$450.00
Price vs. fair value+15.8%Trading above the estimate
Star rating★★☆☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrent5y averagePercentile vs. own historyIndustry rank
PB 6.42 6.42 61% (pricier than usual) #4541 of 5302 (1 = cheapest)
PE 29.89 -19.33 79% (pricier than usual) #2069 of 2975 (1 = cheapest)
PS 10.34 9.76 68% (pricier than usual) #4414 of 5141 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies.

Morningstar view

Star rating★★
Fair value estimate$450.00
Economic moatNarrow
UncertaintyHigh
Scroll to Top